{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:55:15Z","timestamp":1782874515985,"version":"3.54.5"},"reference-count":24,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","award":["DZMG-QNZX-24012"],"award-info":[{"award-number":["DZMG-QNZX-24012"]}],"id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Mens Health"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>\n                    This study aims to analyze the registration information and outcome transparency for five common andrological diseases, as well as the factors influencing result availability. A comprehensive search was performed on ClinicalTrials.gov and the International Clinical Trials Registry Platform (ICTRP) to retrieve all clinical trial registration data related to the five defined andrological diseases from the inception of these databases up to September 1, 2024. The search extracted key trial details, including status, type, intervention, and result availability. Of 8,132 trials retrieved, 642 were analyzed. Among these, 259 trials (40.34%) reported results via ClinicalTrials.gov, ICTRP, or publications, while 113 trials (17.60%) made results publicly available on ClinicalTrials.gov or ICTRP. Among the five andrological diseases, male infertility had the highest rate of result availability (37\/74, 50%), whereas benign prostatic hyperplasia exhibited the lowest (71\/190, 37.37%). No significant differences were found across diseases (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20093.722,\n                    <jats:italic toggle=\"yes\">df<\/jats:italic>\n                    \u2009=\u20094,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009=\u2009.435). Factors such as study status, blinding, interventions, center type, location, and duration significantly influenced result availability, whereas study type, stage, funding, outcome indicators, and sample size did not. Clinical trials on andrological conditions show major gaps in registration and result disclosure, with low reporting rates and prevalent non-reporting and selective reporting. Developed countries dominate trial registration and result disclosure while developing countries have limited participation. Trial characteristics also influence result disclosure rates. These challenges compromise the integrity and credibility of research data, impede clinical practice, and hinder the progress of medical research. Measures are needed to improve transparency, reduce selective reporting, and enhance the rigor and credibility of andrology research.\n                  <\/jats:p>","DOI":"10.1177\/15579883251325478","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:01:21Z","timestamp":1745193681000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Current Status of Clinical Trial Registrations in Andrological Diseases: Insights from ClinicalTrials.gov and ICTRP Databases"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1763-6052","authenticated-orcid":false,"given":"Li-Xing","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hao","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-9793","authenticated-orcid":false,"given":"Jun-Long","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-2229","authenticated-orcid":false,"given":"Hua-Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Ke","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xuan","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"},{"name":"The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Andrology, Traditional Chinese Hospital of Xiamen, Fujian, China"},{"name":"The First Clinical Medical College, Fujian University of Traditional Chinese Medicine, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-076X","authenticated-orcid":false,"given":"Ji-Sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Agarwal A. Mulgund A. Hamada A. Chyatte M. R. (2015). A unique view on male infertility around the globe. Reproductive Biology and Endocrinology: RB&E 13 37. https:\/\/doi.org\/10.1186\/s12958-015-0032-1","DOI":"10.1186\/s12958-015-0032-1"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Becker J. E. Krumholz H. M. Ben-Josef G. Ross J. S. (2014). Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA 311(10) 1063\u20131065. https:\/\/doi.org\/10.1001\/jama.2013.285634","DOI":"10.1001\/jama.2013.285634"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"DeVito N. J. Bacon S. Goldacre B. (2020). Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: A cohort study. Lancet (London England) 395(10221) 361\u2013369. https:\/\/doi.org\/10.1016\/S0140-6736(19)33220-9","DOI":"10.1016\/S0140-6736(19)33220-9"},{"key":"e_1_3_3_5_1","first-page":"1","article-title":"Regulation (EU) No 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC","author":"European Parliament and Council","year":"2014","unstructured":"European Parliament and Council. (2014). Regulation (EU) No 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC. Official Journal of the European Union, L158, 1\u201376.","journal-title":"Official Journal of the European Union, L158"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Gandhi R. Jan M. Smith H. N. Mahomed N. N. Bhandari M. (2011). Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov. BMC Musculoskeletal Disorders 12 278. https:\/\/doi.org\/10.1186\/1471-2474-12-278","DOI":"10.1186\/1471-2474-12-278"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Garg S. Rizvi A. Wee D. Rizvi Y. Rizvi F. Rizvi A. Thomas S. L. Inamdar S. Trindade A. J. (2023). Clinical trial transparency in gastrointestinal endoscopy research. Endoscopy 55(1) 36\u201341. https:\/\/doi.org\/10.1055\/a-1855-7870","DOI":"10.1055\/a-1855-7870"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Garg S. Rizvi A. Wee D. Sreenivasan A. Suchman K. Thomas S. L. Inamdar S. Trindade A. J. (2022). Gastroenterology clinical trials transparency: An analysis of publication rates from the ClinicalTrials.gov database. The American Journal of Gastroenterology 117(1) 180\u2013183. https:\/\/doi.org\/10.14309\/ajg.0000000000001517","DOI":"10.14309\/ajg.0000000000001517"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Huang R. Q. Zhou Y. Zheng H. X. Wang D. Zheng X. Y. Li Z. S. Hu L. H. (2023). Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database. Frontiers in Oncology 12 1026268. https:\/\/doi.org\/10.3389\/fonc.2022.1026268","DOI":"10.3389\/fonc.2022.1026268"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Kiani Z. Simbar M. Rashidi F. Zayeri F. Banaderakhsh H. (2024). The quality of life of men experiencing infertility: A systematic review. BMC Public Health 24(1) 1236. https:\/\/doi.org\/10.1186\/s12889-024-18758-6","DOI":"10.1186\/s12889-024-18758-6"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Magnani C. J. Steinberg J. R. Harmange C. I. Zhang X. Driscoll C. Bell A. Larson J. You J. G. Weeks B. T. Hernandez-Boussard T. Turner B. E. Brooks J. D. (2021). Clinical trial outcomes in urology: Assessing early discontinuation results reporting and publication in ClinicalTrials.Gov Registrations 2007\u20132019. The Journal of Urology 205(4) 1159\u20131168. https:\/\/doi.org\/10.1097\/JU.0000000000001432","DOI":"10.1097\/JU.0000000000001432"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Negoro T. Okura H. Maehata M. Hayashi S. Yoshida S. Takada N. Matsuyama A. (2019). Trends in clinical trials for stroke by cell therapy: Data mining ClinicalTrials.gov and the ICTRP portal site. NPJ Regenerative medicine 4 20. https:\/\/doi.org\/10.1038\/s41536-019-0082-7","DOI":"10.1038\/s41536-019-0082-7"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Nicol A. Chung E. (2023). Male sexual dysfunction: Clinical diagnosis and management strategies for common sexual problems. Australian Journal of General Practice 52(1\u20132) 41\u201345. https:\/\/doi.org\/10.31128\/AJGP-09-22-6559","DOI":"10.31128\/AJGP-09-22-6559"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Prayle A. P. Hurley M. N. Smyth A. R. (2012). Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: Cross sectional study. BMJ 344 d7373. https:\/\/doi.org\/10.1136\/bmj.d7373","DOI":"10.1136\/bmj.d7373"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Psotka M. A. Latta F. Cani D. Fiuzat M. Sbolli M. Barnett S. Metra M. O\u2019Connor C. M. (2020). Publication rates of heart failure clinical trials remain low. Journal of the American College of Cardiology 75(25) 3151\u20133161. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.068","DOI":"10.1016\/j.jacc.2020.04.068"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Ross J. S. Mulvey G. K. Hines E. M. Nissen S. E. Krumholz H. M. (2009). Trial publication after registration in ClinicalTrials.Gov: A cross-sectional analysis. PLoSmedicine 6(9) e1000144. https:\/\/doi.org\/10.1371\/journal.pmed.1000144","DOI":"10.1371\/journal.pmed.1000144"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Ross J. S. Tse T. Zarin D. A. Xu H. Zhou L. Krumholz H. M. (2012). Publication of NIH funded trials registered in ClinicalTrials.gov: Cross sectional analysis. BMJ 344 d7292. https:\/\/doi.org\/10.1136\/bmj.d7292","DOI":"10.1136\/bmj.d7292"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Saito H. Gill C. J. (2014). How frequently do the results from completed US clinical trials enter the public domain?\u2013A statistical analysis of the ClinicalTrials.gov database. PloS One 9(7) e101826. https:\/\/doi.org\/10.1371\/journal.pone.0101826","DOI":"10.1371\/journal.pone.0101826"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Siena L. M. Papamanolis L. Siebert M. J. Bellomo R. K. Ioannidis J. P. A. (2023). Industry involvement and transparency in the most cited clinical trials 2019\u20132022. JAMA Network Open 6(11) e2343425. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.43425","DOI":"10.1001\/jamanetworkopen.2023.43425"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Smith H. N. Bhandari M. Mahomed N. N. Jan M. Gandhi R. (2012). Comparison of arthroplasty trial publications after registration in ClinicalTrials.gov. The Journal of Arthroplasty 27(7) 1283\u20131288. https:\/\/doi.org\/10.1016\/j.arth.2011.11.005","DOI":"10.1016\/j.arth.2011.11.005"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Tse T. Fain K. M. Zarin D. A. (2018). How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider. BMJ (Clinical research ed.) 361 k1452. https:\/\/doi.org\/10.1136\/bmj.k1452","DOI":"10.1136\/bmj.k1452"},{"key":"e_1_3_3_22_1","author":"U.S. Congress","year":"2007","unstructured":"U.S. Congress. (2007). Food and drug administration amendments act of 2007 (FDAAA 801). Public Law No. 110-85, 121 Stat. 823.","journal-title":"Food and drug administration amendments act of 2007 (FDAAA 801)"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Wang C. Zhong Q. Colonnello E. Xi Y. Sansone A. Zhang H. Chen Q. Jannini E. A. Zhang Y. (2024). The patient-perceived intravaginal ejaculation latency time cut-off for lifelong premature ejaculation. Andrology. Advance online publication. https:\/\/doi.org\/10.1111\/andr.13737","DOI":"10.1093\/jsxmed\/qdae161.072"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Zhang J. Liang C. Shang X. Li H. (2020). Chronic prostatitis\/chronic pelvic pain syndrome: A disease or symptom? Current perspectives on diagnosis treatment and prognosis. American Journal of Men\u2019s Health 14(1) 1557988320903200. https:\/\/doi.org\/10.1177\/1557988320903200","DOI":"10.1177\/1557988320903200"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Zhang W. Zhang X. Li H. Wu F. Wang H. Zhao M. Hu H. Xu K. (2019). Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS\/BPH) in China: results from the China Health and Retirement Longitudinal Study. BMJ Open 9(6) e022792. https:\/\/doi.org\/10.1136\/bmjopen-2018-022792","DOI":"10.1136\/bmjopen-2018-022792"}],"container-title":["American Journal of Men's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251325478","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15579883251325478","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251325478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:28:08Z","timestamp":1777505288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15579883251325478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/15579883251325478"],"URL":"https:\/\/doi.org\/10.1177\/15579883251325478","relation":{},"ISSN":["1557-9883","1557-9891"],"issn-type":[{"value":"1557-9883","type":"print"},{"value":"1557-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"article-number":"15579883251325478"}}